pubmed.ncbi.nlm.nih.gov

Mold and Human Health: a Reality Check - PubMed

Review

Mold and Human Health: a Reality Check

Andrea T Borchers et al. Clin Rev Allergy Immunol. 2017 Jun.

Abstract

There are possibly millions of mold species on earth. The vast majority of these mold spores live in harmony with humans, rarely causing disease. The rare species that does cause disease does so by triggering allergies or asthma, or may be involved in hypersensitivity diseases such as allergic bronchopulmonary aspergillosis or allergic fungal sinusitis. Other hypersensitivity diseases include those related to occupational or domiciliary exposures to certain mold species, as in the case of Pigeon Breeder's disease, Farmer's lung, or humidifier fever. The final proven category of fungal diseases is through infection, as in the case of onchomycosis or coccidiomycosis. These diseases can be treated using anti-fungal agents. Molds and fungi can also be particularly important in infections that occur in immunocompromised patients. Systemic candidiasis does not occur unless the individual is immunodeficient. Previous reports of "toxic mold syndrome" or "toxic black mold" have been shown to be no more than media hype and mass hysteria, partly stemming from the misinterpreted concept of the "sick building syndrome." There is no scientific evidence that exposure to visible black mold in apartments and buildings can lead to the vague and subjective symptoms of memory loss, inability to focus, fatigue, and headaches that were reported by people who erroneously believed that they were suffering from "mycotoxicosis." Similarly, a causal relationship between cases of infant pulmonary hemorrhage and exposure to "black mold" has never been proven. Finally, there is no evidence of a link between autoimmune disease and mold exposure.

Keywords: Allergic bronchopulmonary aspergillosis; Allergic fungal sinusitis; Allergic rhinitis; Asthma; Fungi; Hypersensitivity pneumonitis; Mycotoxicosis; Mycotoxins; Sick building syndrome.

PubMed Disclaimer

Cited by

The Myth of Mycotoxins and Mold Injury.
Chang C, Gershwin ME. Chang C, et al. Clin Rev Allergy Immunol. 2019 Dec;57(3):449-455. doi: 10.1007/s12016-019-08767-4. Clin Rev Allergy Immunol. 2019. PMID: 31608429 Review.
Indoor Environmental Interventions for Furry Pet Allergens, Pest Allergens, and Mold: Looking to the Future.
Ahluwalia SK, Matsui EC. Ahluwalia SK, et al. J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):9-19. doi: 10.1016/j.jaip.2017.10.009. J Allergy Clin Immunol Pract. 2018. PMID: 29310769 Free PMC article. Review.
Ten questions concerning occupant health in buildings during normal operations and extreme events including the COVID-19 pandemic.
Awada M, Becerik-Gerber B, Hoque S, O'Neill Z, Pedrielli G, Wen J, Wu T. Awada M, et al. Build Environ. 2021 Jan 15;188:107480. doi: 10.1016/j.buildenv.2020.107480. Epub 2020 Nov 24. Build Environ. 2021. PMID: 36570375 Free PMC article.
Is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? A proof-of-concept study.
Liebers V, Kespohl S, Borowitzki G, Stubel H, Raulf M. Liebers V, et al. Allergol Select. 2022 Mar 29;6:133-141. doi: 10.5414/ALX02299E. eCollection 2022. Allergol Select. 2022. PMID: 35392213 Free PMC article.
First Insight into the Degradome of Aspergillus ochraceus: Novel Secreted Peptidases and Their Inhibitors.
Shestakova A, Fatkulin A, Surkova D, Osmolovskiy A, Popova E. Shestakova A, et al. Int J Mol Sci. 2024 Jun 28;25(13):7121. doi: 10.3390/ijms25137121. Int J Mol Sci. 2024. PMID: 39000228 Free PMC article.

References

1. J Air Waste Manag Assoc. 2012 Dec;62(12):1380-93 - PubMed
1. J Autoimmun. 2016 Jan;66:60-75 - PubMed
1. Indoor Air. 2011 Jun;21(3):253-63 - PubMed
1. Indoor Air. 2016 Dec;26(6):880-891 - PubMed
1. Clin Rev Allergy Immunol. 2017 Apr;52(2):260-272 - PubMed

Mold and Human Health: a Reality Check - PubMed